← SynDRA
BCI-hydrochloride
SynDRA canonical compound SYN0062891 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
| Primary target(s) | DUSP6 |
| Mechanism of action | Protein phosphatase inhibitor |
All known targets
Mechanisms of action (all sources)
- Protein phosphatase inhibitor
- MAP kinase phosphatase inhibitor
Cross-references
Synonyms
- CID-5458317
- C22H23NO
- Dual Specificity Protein Phosphatase 1/6 Inhibitor
- 3-(cyclohexylamino)-2-(phenylmethylene)-3H-inden-1-one
- NSC150117
- (E)-BCI
- NSC 150117
- 2-benzylidene-3-(cyclohexylamino)-3H-inden-1-one
- orb1309724
- SCHEMBL3698122
- XJDKPLZUXCIMIS-UHFFFAOYSA-N
- QAA98284
- VZB79251
- NCI60_001042
- 2-Benzylidene-3-cyclohexylamino-indan-1-one
- 2-benzylidene-3-(cyclohexylamino)-1-indanone
- G90870
Look up BCI-hydrochloride in the interactive SynDRA portal →